BioPharm International - October 2020

BioPharm- October - Regulatory Sourcebook

Issue link: https://www.e-digitaleditions.com/i/1300450

Contents of this Issue

Navigation

Page 10 of 59

Get fast, accurate results for next generation biologics Are you looking to bring safe, effective therapies to market sooner? A complete suite of instruments and solutions from SCIEX can help. Through the precision analytics of SCIEX CE and LC-MS/MS technology, get the answers you need to accelerate your drug development. Whether you are investigating monoclonal antibodies, multi-specifics, mRNA, oligonucleotides or gene therapies, SCIEX has your next generation biologics research and development needs covered. Discover ways to accelerate your next generation biologics development by getting the right answers the first time, through precise analytics you can trust. For more information visit sciex.li/next-gen-biologics-solutions Trusted precision to help you accelerate drug discovery and development Gene_Therapy_Compendium.indd 17 Gene_Therapy_Compendium.indd 17 1/31/20 9:06 AM 1/31/20 9:06 AM The SCIEX clinical diagnostic portfolio is For In Vitro Diagnostic Use. Rx Only. Product(s) not available in all countries. For information on availability, please contact your local sales representative or refer to https:// sciex.com/diagnostics. All other products are For Research Use Only. Not for use in Diagnostic Procedures. Trademarks and/or registered trademarks mentioned herein are the property of AB Sciex Pte. Ltd. or their respective owners in the United States and/or certain other countries. © 2020 DH Tech. Dev. Pte. Ltd. DOC-RUO-MKT-13-10984-A

Articles in this issue

Links on this page

Archives of this issue

view archives of BioPharm International - October 2020 - BioPharm- October - Regulatory Sourcebook